Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Sarepta Therapeutics, Inc. (SRPT) since 2005 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Sarepta Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 873303.
Total stock buying since 2005: $52,125,608.
Total stock sales since 2005: $170,656,948.
Total stock option exercises since 2005: $28,350,795.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2025 | 0 | $0 | 2,491 | $248,203 | 144,642 | $1,231,667 |
2024 | 37,038 | $4,960,499 | 96,566 | $14,056,256 | 95,250 | $2,036,050 |
2023 | 143,757 | $13,292,291 | 15,000 | $1,600,800 | 30,000 | $870,900 |
2022 | 103,270 | $10,980,220 | 858 | $94,311 | 20,000 | $698,400 |
2021 | 28,806 | $2,300,445 | 15,000 | $1,263,900 | 20,967 | $611,100 |
2020 | 0 | $0 | 188,487 | $30,358,072 | 133,260 | $2,774,674 |
2019 | 43,152 | $4,846,856 | 455,000 | $58,762,762 | 582,185 | $11,906,011 |
2018 | 32,695 | $4,017,625 | 282,973 | $37,226,372 | 221,125 | $2,904,632 |
2017 | 85,196 | $3,999,921 | 131,223 | $5,746,828 | 198,320 | $1,825,833 |
2016 | 154,500 | $2,470,070 | 177,703 | $8,941,400 | 157,842 | $1,475,161 |
2015 | 1,600 | $18,904 | 0 | $0 | 0 | $0 |
2013 | 35,500 | $1,050,758 | 21,489 | $394,449 | 5,556 | $97,341 |
2012 | 47,500 | $296,887 | 53,000 | $1,027,029 | 0 | $0 |
2011 | 570,000 | $572,700 | 0 | $0 | 0 | $0 |
2010 | 278,107 | $386,606 | 5,784,411 | $7,991,553 | 1,617,000 | $1,919,026 |
2009 | 949,400 | $960,929 | 333,950 | $475,878 | 0 | $0 |
2008 | 1,267,252 | $1,910,397 | 119,048 | $141,458 | 0 | $0 |
2006 | 5,000 | $31,800 | 840,000 | $2,327,677 | 0 | $0 |
2005 | 12,000 | $28,700 | 0 | $0 | 0 | $0 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2025-05 | 0 | $0 | 0 | $0 | 32,596 | $796,663 |
2025-03 | 0 | $0 | 2,491 | $248,203 | 96,246 | $245,404 |
2025-01 | 0 | $0 | 0 | $0 | 15,800 | $189,600 |
2024-12 | 0 | $0 | 12,136 | $1,516,219 | 10,500 | $143,955 |
2024-08 | 37,038 | $4,960,499 | 5,985 | $822,099 | 0 | $0 |
2024-07 | 0 | $0 | 0 | $0 | 15,000 | $208,500 |
2024-06 | 0 | $0 | 50,714 | $8,220,385 | 54,750 | $1,475,095 |
2024-05 | 0 | $0 | 3,635 | $508,900 | 0 | $0 |
2024-03 | 0 | $0 | 24,096 | $2,988,653 | 15,000 | $208,500 |
2023-11 | 75,225 | $5,957,617 | 0 | $0 | 15,000 | $435,450 |
2023-08 | 68,532 | $7,334,674 | 15,000 | $1,600,800 | 15,000 | $435,450 |
2022-12 | 0 | $0 | 0 | $0 | 20,000 | $698,400 |
2022-11 | 0 | $0 | 858 | $94,311 | 0 | $0 |
2022-09 | 57,100 | $5,970,775 | 0 | $0 | 0 | $0 |
2022-08 | 46,170 | $5,009,445 | 0 | $0 | 0 | $0 |
2021-12 | 0 | $0 | 0 | $0 | 5,967 | $50,400 |
2021-11 | 28,806 | $2,300,445 | 0 | $0 | 0 | $0 |
2021-03 | 0 | $0 | 15,000 | $1,263,900 | 15,000 | $560,700 |
2020-12 | 0 | $0 | 2,240 | $363,975 | 3,207 | $112,966 |
2020-08 | 0 | $0 | 41,125 | $6,530,175 | 11,125 | $382,500 |
2020-07 | 0 | $0 | 0 | $0 | 3,806 | $76,184 |
2020-06 | 0 | $0 | 105,122 | $17,877,572 | 105,122 | $2,110,324 |
2020-05 | 0 | $0 | 35,000 | $5,001,900 | 5,000 | $50,400 |
2020-03 | 0 | $0 | 5,000 | $584,450 | 5,000 | $42,300 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-05-16 | Barry Richard | Option Ex | 12,350 | 32.63 | 402,980 |
2025-05-13 | Barry Richard | Option Ex | 20,246 | 19.45 | 393,683 |
2025-03-12 | Nicaise Claude | Sale | 2,491 | 99.64 | 248,203 |
2025-03-12 | Nicaise Claude | Option Ex | 9,746 | 25.18 | 245,404 |
2025-03-07 | Murray Dallan (Chief Customer Officer) | Option Ex | 5,500 | .00 | 0 |
2025-03-07 | Estepan Ian Michael (Chief Financial Officer) | Option Ex | 5,500 | .00 | 0 |
2025-03-07 | Rodino-klapac Louise (Head of R&D, CSO) | Option Ex | 5,500 | .00 | 0 |
2025-03-06 | Murray Dallan (Chief Customer Officer) | Option Ex | 17,500 | .00 | 0 |
2025-03-06 | Arif Bilal (Chief Tech Ops Officer) | Option Ex | 17,500 | .00 | 0 |
2025-03-06 | Estepan Ian Michael (Chief Financial Officer) | Option Ex | 17,500 | .00 | 0 |
2025-03-06 | Rodino-klapac Louise (Head of R&D, CSO) | Option Ex | 17,500 | .00 | 0 |
2025-01-29 | Estepan Ian Michael (Chief Financial Officer) | Option Ex | 15,800 | 12.00 | 189,600 |
2024-12-12 | Wigzell Hans Lennart Rudolf | Sale | 10,500 | 124.84 | 1,310,820 |
2024-12-12 | Wigzell Hans Lennart Rudolf | Option Ex | 10,500 | 13.71 | 143,955 |
2024-12-05 | Boor Kathryn Jean | Sale | 1,636 | 125.55 | 205,399 |
2024-08-30 | Estepan Ian Michael (Chief Financial Officer) | Sale | 5,985 | 137.36 | 822,099 |
2024-08-16 | Chambers Michael Andrew | Buy | 37,038 | 133.93 | 4,960,499 |
2024-07-03 | Behrens M Kathleen | Option Ex | 15,000 | 13.90 | 208,500 |
2024-06-25 | Arif Bilal (Chief Tech Ops Officer) | Sale | 3,898 | 163.23 | 636,270 |
2024-06-25 | Brown Ryan Edward (EVP, General Counsel) | Sale | 38,957 | 161.43 | 6,288,984 |
2024-06-25 | Brown Ryan Edward (EVP, General Counsel) | Option Ex | 23,500 | 62.77 | 1,475,095 |
2024-06-24 | Arif Bilal (Chief Tech Ops Officer) | Sale | 7,859 | 164.80 | 1,295,131 |
2024-06-21 | Murray Dallan (Chief Customer Officer) | Option Ex | 6,250 | .00 | 0 |
2024-06-21 | Arif Bilal (Chief Tech Ops Officer) | Option Ex | 6,250 | .00 | 0 |
2024-06-21 | Brown Ryan Edward (EVP, General Counsel) | Option Ex | 6,250 | .00 | 0 |
2024-06-21 | Estepan Ian Michael (Chief Financial Officer) | Option Ex | 6,250 | .00 | 0 |
2024-06-21 | Rodino-klapac Louise (Head of R&D, CSO) | Option Ex | 6,250 | .00 | 0 |
2024-05-02 | Murray Dallan (Chief Customer Officer) | Sale | 3,635 | 140.00 | 508,900 |
2024-03-11 | Boor Kathryn Jean | Sale | 761 | 122.93 | 93,549 |
2024-03-08 | Wigzell Hans Lennart Rudolf | Sale | 15,000 | 123.11 | 1,846,695 |
2024-03-08 | Wigzell Hans Lennart Rudolf | Option Ex | 15,000 | 13.90 | 208,500 |
2024-03-05 | Mayo Stephen | Sale | 3,135 | 122.96 | 385,479 |
2024-03-01 | Arif Bilal (Chief Tech Ops Officer) | Sale | 2,000 | 129.15 | 258,290 |
2024-03-01 | Brown Ryan Edward (EVP, General Counsel) | Sale | 2,000 | 125.34 | 250,680 |
2024-03-01 | Estepan Ian Michael (Chief Financial Officer) | Sale | 1,200 | 128.30 | 153,960 |
2023-11-03 | Barry Richard (Director) | Buy | 50,000 | 78.81 | 3,940,500 |
2023-11-03 | Behrens M Kathleen (Director) | Option Ex | 15,000 | 29.03 | 435,450 |
2023-11-03 | Ingram Douglas S (President & CEO) | Buy | 25,225 | 79.97 | 2,017,117 |
2023-08-14 | Chambers Michael Andrew (Director) | Buy | 9,979 | 109.54 | 1,093,099 |
2023-08-11 | Chambers Michael Andrew (Director) | Buy | 23,686 | 108.05 | 2,559,272 |
2023-08-10 | Chambers Michael Andrew (Director) | Buy | 34,867 | 105.61 | 3,682,303 |
2023-08-04 | Wigzell Hans Lennart Rudolf (Director) | Sale | 15,000 | 106.72 | 1,600,800 |
2023-08-04 | Wigzell Hans Lennart Rudolf (Director) | Option Ex | 15,000 | 29.03 | 435,450 |
2022-12-19 | Behrens M Kathleen (Director) | Option Ex | 20,000 | 34.92 | 698,400 |
2022-11-17 | Mayo Stephen (Director) | Sale | 858 | 109.92 | 94,311 |
2022-09-14 | Chambers Michael Andrew (Director) | Buy | 57,100 | 104.57 | 5,970,775 |
2022-08-19 | Chambers Michael Andrew (Director) | Buy | 46,170 | 108.50 | 5,009,445 |
2021-12-15 | Behrens M Kathleen (Director) | Option Ex | 5,000 | 10.08 | 50,400 |
2021-12-10 | Gray Mary Ann (Director) | Option Ex | 967 | .00 | 0 |
2021-11-24 | Rodino-klapac Louise (Head of R&D, CSO) | Buy | 3,780 | 79.33 | 299,867 |
2021-11-17 | Ingram Douglas S (President & CEO) | Buy | 25,026 | 79.94 | 2,000,578 |
2021-03-10 | Behrens M Kathleen (Director) | Sale | 5,000 | 85.76 | 428,800 |
2021-03-10 | Behrens M Kathleen (Director) | Option Ex | 5,000 | 42.30 | 211,500 |
2021-03-08 | Wigzell Hans Lennart Rudolf (Director) | Sale | 10,000 | 83.51 | 835,100 |
2021-03-08 | Wigzell Hans Lennart Rudolf (Director) | Option Ex | 10,000 | 34.92 | 349,200 |
2020-12-11 | Bratica Joseph (Principal Financial Officer) | Sale | 1,115 | 165.00 | 183,975 |
2020-12-11 | Bratica Joseph (Principal Financial Officer) | Option Ex | 1,115 | 71.45 | 79,666 |
2020-12-10 | Gray Mary Ann (Director) | Option Ex | 967 | .00 | 0 |
2020-12-08 | Bratica Joseph (Principal Financial Officer) | Sale | 1,125 | 160.00 | 180,000 |
2020-12-08 | Bratica Joseph (Principal Financial Officer) | Option Ex | 1,125 | 29.60 | 33,300 |
2020-08-10 | Wigzell Hans Lennart Rudolf (Director) | Sale | 10,000 | 159.30 | 1,593,000 |
2020-08-10 | Wigzell Hans Lennart Rudolf (Director) | Option Ex | 10,000 | 34.92 | 349,200 |
2020-08-07 | Barry Richard (Director) | Sale | 30,000 | 158.76 | 4,762,800 |
2020-08-03 | Bratica Joseph (Principal Financial Officer) | Sale | 1,125 | 155.00 | 174,375 |
2020-08-03 | Bratica Joseph (Principal Financial Officer) | Option Ex | 1,125 | 29.60 | 33,300 |
2020-07-08 | Mahatme Sandesh (EVP, CFO & CBO) | Option Ex | 3,806 | 20.02 | 76,184 |
2020-06-22 | Howton David T (EVP, General Counsel) | Sale | 105,122 | 170.06 | 17,877,572 |
2020-06-22 | Howton David T (EVP, General Counsel) | Option Ex | 105,122 | 20.07 | 2,110,324 |
2020-05-20 | Wigzell Hans Lennart Rudolf (Director) | Sale | 5,000 | 150.87 | 754,350 |
2020-05-20 | Wigzell Hans Lennart Rudolf (Director) | Option Ex | 5,000 | 10.08 | 50,400 |
2020-05-15 | Barry Richard (Director) | Sale | 30,000 | 141.59 | 4,247,550 |
2020-03-04 | Wigzell Hans Lennart Rudolf (Director) | Sale | 5,000 | 116.89 | 584,450 |
2020-03-04 | Wigzell Hans Lennart Rudolf (Director) | Option Ex | 5,000 | 8.46 | 42,300 |
2019-12-13 | Cumbo Alexander (EVP, Chief Commercial Officer) | Sale | 42,000 | 125.50 | 5,271,000 |
2019-12-13 | Cumbo Alexander (EVP, Chief Commercial Officer) | Option Ex | 32,706 | 17.89 | 585,012 |
2019-12-13 | Howton David T (EVP, General Counsel) | Sale | 78,000 | 125.50 | 9,789,000 |
2019-12-13 | Howton David T (EVP, General Counsel) | Option Ex | 78,000 | 18.88 | 1,472,250 |
2019-12-13 | Mahatme Sandesh (EVP, CFO & CBO) | Sale | 125,000 | 125.50 | 15,687,500 |
2019-12-13 | Mahatme Sandesh (EVP, CFO & CBO) | Option Ex | 125,000 | 24.64 | 3,080,250 |
2019-12-10 | Gray Mary Ann (Director) | Option Ex | 967 | .00 | 0 |
2019-11-22 | Howton David T (EVP, General Counsel) | Sale | 25,000 | 105.00 | 2,625,000 |
2019-11-22 | Howton David T (EVP, General Counsel) | Option Ex | 34,272 | 15.21 | 521,379 |
2019-09-13 | Barry Richard (Director) | Buy | 3,309 | 87.49 | 289,504 |
2019-09-12 | Barry Richard (Director) | Buy | 1,691 | 87.49 | 147,950 |
2019-09-09 | Bonney Michael W (Director) | Buy | 2,000 | 86.74 | 173,480 |
2019-09-06 | Behrens M Kathleen (Director) | Buy | 2,500 | 87.98 | 219,950 |
2019-09-05 | Behrens M Kathleen (Director) | Option Ex | 5,000 | 7.80 | 39,000 |
2019-08-21 | Mahatme Sandesh (EVP, CFO & CBO) | Option Ex | 100,000 | 23.85 | 2,385,000 |
2019-08-20 | Barry Richard (Director) | Buy | 5,000 | 99.32 | 496,595 |
2019-08-15 | Mahatme Sandesh (EVP, CFO & CBO) | Option Ex | 9,754 | 21.05 | 205,360 |
2019-08-14 | Barry Richard (Director) | Buy | 7,400 | 122.50 | 906,500 |
2019-08-12 | Barry Richard (Director) | Buy | 1,300 | 122.50 | 159,250 |
2019-08-12 | Ingram Douglas S (President & CEO) | Buy | 16,252 | 123.08 | 2,000,377 |
2019-05-23 | O'neill Gilmore Neil (EVP, R&D & CMO) | Option Ex | 12,000 | .00 | 0 |
2019-05-23 | Wigzell Hans Lennart Rudolf (Director) | Sale | 10,000 | 120.00 | 1,200,000 |
2019-05-23 | Wigzell Hans Lennart Rudolf (Director) | Option Ex | 10,000 | 7.80 | 78,000 |
2019-03-19 | Mahatme Sandesh (EVP, CFO & CBO) | Option Ex | 15,486 | 16.29 | 252,313 |
2019-02-07 | Mahatme Sandesh (EVP, CFO & CBO) | Sale | 65,000 | 145.00 | 9,425,000 |
2019-02-07 | Mahatme Sandesh (EVP, CFO & CBO) | Option Ex | 65,000 | 23.85 | 1,550,250 |
2019-02-01 | Cumbo Alexander (SVP, Chief Commercial Officer) | Sale | 15,000 | 140.00 | 2,100,000 |
2019-02-01 | Cumbo Alexander (SVP, Chief Commercial Officer) | Option Ex | 7,500 | 20.07 | 150,525 |
2019-02-01 | Howton David T (SVP, General Counsel) | Sale | 30,000 | 140.00 | 4,200,000 |
2019-02-01 | Howton David T (SVP, General Counsel) | Option Ex | 21,500 | 17.09 | 367,435 |
2019-01-31 | Mahatme Sandesh (EVP, CFO & CBO) | Sale | 21,198 | 130.72 | 2,771,002 |
2019-01-31 | Mahatme Sandesh (EVP, CFO & CBO) | Option Ex | 21,198 | 23.85 | 505,572 |
2019-01-30 | Mahatme Sandesh (EVP, CFO & CBO) | Sale | 43,802 | 130.00 | 5,694,260 |
2019-01-30 | Mahatme Sandesh (EVP, CFO & CBO) | Option Ex | 43,802 | 16.29 | 713,665 |
2018-11-01 | Wigzell Hans Lennart Rudolf (Director) | Sale | 6,667 | 140.50 | 936,713 |
2018-11-01 | Wigzell Hans Lennart Rudolf (Director) | Option Ex | 6,667 | 8.94 | 59,602 |
2018-10-31 | Behrens M Kathleen (Director) | Sale | 10,000 | 131.71 | 1,317,100 |
2018-10-31 | Behrens M Kathleen (Director) | Option Ex | 10,000 | 3.96 | 39,600 |
2018-10-30 | Ingram Douglas S (President & CEO) | Buy | 16,695 | 120.60 | 2,013,417 |
2018-10-24 | Mahatme Sandesh (EVP, CFO & CBO) | Sale | 107,524 | 127.74 | 13,735,115 |
2018-10-24 | Mahatme Sandesh (EVP, CFO & CBO) | Option Ex | 89,400 | 16.29 | 1,456,594 |
2018-08-15 | Ingram Douglas S (President & CEO) | Buy | 16,000 | 125.26 | 2,004,208 |
2018-07-16 | Howton David T (SVP, General Counsel) | Sale | 50,000 | 136.46 | 6,823,000 |
2018-07-16 | Howton David T (SVP, General Counsel) | Option Ex | 50,000 | 13.77 | 688,650 |
2018-07-09 | Cumbo Alexander (SVP, Chief Commercial Officer) | Sale | 33,782 | 137.32 | 4,638,944 |
2018-07-09 | Cumbo Alexander (SVP, Chief Commercial Officer) | Option Ex | 33,782 | 13.77 | 465,279 |
2018-06-27 | Barry Richard (Director) | Sale | 75,000 | 130.34 | 9,775,500 |
2018-05-22 | Cumbo Alexander (SVP, Chief Commercial Officer) | Option Ex | 4,876 | .00 | 0 |
2018-05-22 | Ruff Shamim (SVP, Chief Regulatory Affairs) | Option Ex | 4,432 | .00 | 0 |
2018-05-22 | Howton David T (SVP, General Counsel) | Option Ex | 5,319 | .00 | 0 |
2018-05-22 | Mahatme Sandesh (EVP, CFO & CBO) | Option Ex | 6,649 | .00 | 0 |
2018-03-15 | Cumbo Alexander (SVP, Chief Commercial Officer) | Option Ex | 2,500 | 16.89 | 42,225 |
2018-03-15 | Ruff Shamim (SVP, Chief Regulatory Affairs) | Option Ex | 2,500 | 20.07 | 50,175 |
2018-03-15 | Howton David T (SVP, General Counsel) | Option Ex | 2,500 | 17.15 | 42,882 |
2018-03-15 | Mahatme Sandesh (EVP, CFO & CBO) | Option Ex | 2,500 | 23.85 | 59,625 |
2017-11-30 | Wigzell Hans Lennart Rudolf (Director) | Sale | 6,667 | 55.89 | 372,618 |
2017-11-30 | Wigzell Hans Lennart Rudolf (Director) | Option Ex | 6,667 | 7.38 | 49,202 |
2017-11-08 | Ingram Douglas S (President & CEO) | Buy | 38,138 | 52.44 | 1,999,956 |
2017-11-06 | Ruff Shamim (SVP, Regulatory Affairs & Qual) | Sale | 10,000 | 55.00 | 550,000 |
2017-11-06 | Ruff Shamim (SVP, Regulatory Affairs & Qual) | Option Ex | 10,000 | 14.76 | 147,600 |
2017-10-03 | Ruff Shamim (SVP, Regulatory Affairs & Qual) | Sale | 11,500 | 50.00 | 575,000 |
2017-10-03 | Ruff Shamim (SVP, Regulatory Affairs & Qual) | Option Ex | 11,500 | 14.76 | 169,740 |
2017-08-03 | Cumbo Alexander (SVP, Chief Commercial Officer) | Option Ex | 9,752 | .00 | 0 |
2017-08-03 | Ruff Shamim (SVP, Regulatory Affairs & Qual) | Option Ex | 8,865 | .00 | 0 |
2017-08-03 | Howton David T (SVP, General Counsel) | Option Ex | 10,639 | .00 | 0 |
2017-08-03 | Kaye Edward M. Md (Director) | Option Ex | 35,461 | .00 | 0 |
2017-08-03 | Mahatme Sandesh (EVP, CFO & CBO) | Option Ex | 13,298 | .00 | 0 |
2017-07-27 | Ingram Douglas S (President & CEO) | Buy | 47,058 | 42.50 | 1,999,965 |
2017-07-21 | Ruff Shamim (SVP, Regulatory Affairs & Qual) | Sale | 5,888 | 44.00 | 259,072 |
2017-07-21 | Ruff Shamim (SVP, Regulatory Affairs & Qual) | Option Ex | 5,888 | 14.33 | 84,375 |
2017-07-21 | Howton David T (SVP, General Counsel) | Option Ex | 1,000 | 18.78 | 18,780 |
2017-07-21 | Mahatme Sandesh (EVP, CFO & CBO) | Option Ex | 1,500 | 23.85 | 35,775 |
2017-07-20 | Cumbo Alexander (SVP, Chief Commercial Officer) | Sale | 5,918 | 41.00 | 242,638 |
2017-07-20 | Cumbo Alexander (SVP, Chief Commercial Officer) | Option Ex | 2,500 | 13.71 | 34,275 |
2017-07-20 | Ruff Shamim (SVP, Regulatory Affairs & Qual) | Sale | 6,250 | 42.00 | 262,500 |
2017-07-20 | Ruff Shamim (SVP, Regulatory Affairs & Qual) | Option Ex | 6,250 | 13.71 | 85,687 |
2017-07-20 | Howton David T (SVP, General Counsel) | Sale | 25,000 | 41.00 | 1,025,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of SRPT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Sarepta Therapeutics, Inc. (symbol SRPT, CIK number 873303) see the Securities and Exchange Commission (SEC) website.